Physician profile
Michael W Griffin
NPI 1912968652
$5,705.17
in general payments reported to CMS, 2019-2025
26 companies · $51.92 in 2025
The $51.92 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,410 · 2020: $1,160 · 2021: $209 · 2022: $167 · 2023: $217 · 2024: $2,489 · 2025: $51.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,381 · Education: $1,000 · Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,381.21 |
| Education | $1,000.00 |
| Food and Beverage | $376.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,639.98 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $2,054.13 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $314.88 | 2019-2022 | |
| Covidien LP | $76.42 | 2019 | |
| Davol INC. | $67.01 | 2021-2023 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $66.44 | 2021-2023 | Gattex |
| Ethicon US, LLC | $59.49 | 2023 | Stratafix, Vistaseal, Echelon; Endopath |
| Conmed Corporation | $48.25 | 2022 | |
| Stryker Corporation | $45.42 | 2023 | Spy-Phi System |
| Depuy Synthes Sales INC. | $32.34 | 2025 | |
| Tei Biosciences INC | $31.07 | 2019 | |
| Heron Therapeutics, INC. | $29.44 | 2021 | |
| Nestle Healthcare Nutrition INC. | $23.43 | 2020 | |
| Boston Scientific Corporation | $23.42 | 2022 | |
| Abbvie INC. | $23.37 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $19.58 | 2025 | Phasix Mesh |
| Baudax Bio INC. | $18.91 | 2021 | |
| Ferring Pharmaceuticals INC. | $18.20 | 2023 | Clenpiq |
| Coopersurgical, INC. | $17.85 | 2024 | Insorb |
| Angiodynamics, INC. | $16.31 | 2023 | Smart Port Ct |
| Cook Medical LLC | $16.26 | 2019 | |
| Integra Lifesciences Corporation | $16.18 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.76 | 2019 | |
| Tela Bio, INC. | $12.03 | 2020 | |
| Medtronic, INC. | $11.56 | 2021 | |
| Acell, INC. | $10.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.